Please use this identifier to cite or link to this item:
Title: Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 3 treatment practicalities and recommendations.
Austin Authors: Broadley, Simon A;Barnett, Michael H;Boggild, Mike;Brew, Bruce J;Butzkueven, Helmut;Heard, Robert;Hodgkinson, Suzanne;Kermode, Allan G;Lechner-Scott, Jeannette;Macdonell, Richard A L ;Marriott, Mark;Mason, Deborah F;Parratt, John;Reddel, Stephen W;Shaw, Cameron P;Slee, Mark;Spies, Judith;Taylor, Bruce V;Carroll, William M;Kilpatrick, Trevor J;King, John;McCombe, Pamela A;Pollard, John D;Willoughby, Ernest
Affiliation: Department of Neurology, Eastern Health and Monash University, 2/5 Arnold Street, Box Hill VIC 3128, Australia
Westmead Clinical School, University of Sydney, NSW, Australia
South Western Sydney Clinical School, University of New South Wales, NSW, Australia
Centre for Neuromuscular and Neurological Disorders, University of Western Australia, WA, Australia
Hunter Medical Research Institute, The University of Newcastle, New Lambton, NSW, Australia
Department of Neurology, Gold Coast University Hospital, Southport, QLD, Australia
Melbourne Brain Centre, Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria, Australia
Department of Neurology, Austin Health, Heidelberg, Victoria, Australia
Central Clinical School, University of Sydney, NSW, Australia
Brain and Mind Research Institute, University of Sydney, Camperdown, NSW, Australia
Department of Neurology and St Vincent's Centre for Applied Medical Research, St Vincent's Hospital, University of New South Wales, Darlinghurst, NSW, Australia
Flinders Medical Centre, Flinders University, SA, Australia
School of Medicine, Deakin University, Victoria, Australia
Menzies Research Institute, University of Tasmania, TAS, Australia
Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia
University of Queensland Centre for Clinical Research, QLD, Australia
Department of Neurology, The Townsville Hospital, Douglas, QLD, Australia
School of Medicine, Griffith University, Gold Coast Campus, QLD 4222, Australia
Department of Neurology, Christchurch Hospital, Christchurch, New Zealand.
Department of Neurology, Auckland City Hospital, Auckland, New Zealand.
Issue Date: 30-Jun-2014
Publication information: Journal of Clinical Neuroscience 2014; 21(11): 1857-65
Abstract: In this third and final part of our review of multiple sclerosis (MS) treatment we look at the practical day-to-day management issues that are likely to influence individual treatment decisions. Whilst efficacy is clearly of considerable importance, tolerability and the potential for adverse effects often play a significant role in informing individual patient decisions. Here we review the issues surrounding switching between therapies, and the evidence to assist guiding the choice of therapy to change to and when to change. We review the current level of evidence with regards to the management of women in their child-bearing years with regards to recommendations about treatment during pregnancy and whilst breast feeding. We provide a summary of recommended pre- and post-treatment monitoring for the available therapies and review the evidence with regards to the value of testing for antibodies which are known to be neutralising for some therapies. We review the occurrence of adverse events, both the more common and troublesome effects and those that are less common but have potentially much more serious outcomes. Ways of mitigating these risks and managing the more troublesome adverse effects are also reviewed. Finally, we make specific recommendations with regards to the treatment of MS. It is an exciting time in the world of MS neurology and the prospects for further advances in coming years are high.
Gov't Doc #: 24993136
DOI: 10.1016/j.jocn.2014.01.017
Type: Journal Article
Subjects: Evidence-based medicine
Multiple sclerosis
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Nov 25, 2022

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.